Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gibb

Showing results (341-350 of 368) with videos related to

Pageof 37
Sort By:
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
British Journal of Clinical Pharmacology|September 4, 2024
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patientsTom G Jacobs, Hylke Waalewijn, Lily Houlden, et al.
The New England Journal of Medicine|August 1, 2019
Immediate Transfusion in African Children with Uncomplicated Severe AnemiaKathryn Maitland, Sarah Kiguli, Peter Olupot-Olupot, et al.
The New England Journal of Medicine|August 1, 2019
Transfusion Volume for Children with Severe Anemia in AfricaKathryn Maitland, Peter Olupot-Olupot, Sarah Kiguli, et al.
BMC Infectious Diseases|January 15, 2021
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L Moore, Anna Turkova, Hilda Mujuru, et al.
Wellcome Open Research|January 18, 2024
Gastroenteritis Rehydration Of children with Severe Acute Malnutrition (GASTROSAM): A Phase II Randomised Controlled trial: Trial ProtocolPeter Olupot-Olupot, Florence Aloroker, Ayub Mpoya, et al.
BMC Medicine|March 19, 2013
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trialKathryn Maitland, Elizabeth C George, Jennifer A Evans, et al.
HIV Medicine|October 1, 2021
Children living with HIV in Europe: do migrants have worse treatment outcomes?Elizabeth Chappell, Malte Kohns Vasconcelos, Ruth L Goodall, et al.
The Lancet. HIV|September 2, 2022
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trialPauline Amuge, Abbas Lugemwa, Ben Wynne, et al.
Pageof 37

Showing results (341-350 of 368) with videos related to

Sort By:
Pageof 37
Trials|April 21, 2018
Shorter treatment for minimal tuberculosis (TB) in children (SHINE): a study protocol for a randomised controlled trialChishala Chabala, Anna Turkova, Margaret J Thomason, et al.
The Lancet. HIV|April 15, 2018
Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trialJane Mallewa, Alexander J Szubert, Peter Mugyenyi, et al.
British Journal of Clinical Pharmacology|September 4, 2024
Influence of age and co-medication on dolutegravir glucuronidation in paediatric patientsTom G Jacobs, Hylke Waalewijn, Lily Houlden, et al.
The New England Journal of Medicine|August 1, 2019
Immediate Transfusion in African Children with Uncomplicated Severe AnemiaKathryn Maitland, Sarah Kiguli, Peter Olupot-Olupot, et al.
The New England Journal of Medicine|August 1, 2019
Transfusion Volume for Children with Severe Anemia in AfricaKathryn Maitland, Peter Olupot-Olupot, Sarah Kiguli, et al.
BMC Infectious Diseases|January 15, 2021
ODYSSEY clinical trial design: a randomised global study to evaluate the efficacy and safety of dolutegravir-based antiretroviral therapy in HIV-positive children, with nested pharmacokinetic sub-studies to evaluate pragmatic WHO-weight-band based dolutegravir dosingCecilia L Moore, Anna Turkova, Hilda Mujuru, et al.
Wellcome Open Research|January 18, 2024
Gastroenteritis Rehydration Of children with Severe Acute Malnutrition (GASTROSAM): A Phase II Randomised Controlled trial: Trial ProtocolPeter Olupot-Olupot, Florence Aloroker, Ayub Mpoya, et al.
BMC Medicine|March 19, 2013
Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trialKathryn Maitland, Elizabeth C George, Jennifer A Evans, et al.
HIV Medicine|October 1, 2021
Children living with HIV in Europe: do migrants have worse treatment outcomes?Elizabeth Chappell, Malte Kohns Vasconcelos, Ruth L Goodall, et al.
The Lancet. HIV|September 2, 2022
Once-daily dolutegravir-based antiretroviral therapy in infants and children living with HIV from age 4 weeks: results from the below 14 kg cohort in the randomised ODYSSEY trialPauline Amuge, Abbas Lugemwa, Ben Wynne, et al.
Pageof 37